WallStSmart

Offerpad Solutions Inc. Class A Common Stock (OPAD)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 3055% more annual revenue ($12.76B vs $404.53M). WELL leads profitability with a 12.1% profit margin vs -9.8%. WELL earns a higher WallStSmart Score of 57/100 (C).

OPAD

Avoid

34

out of 100

Grade: F

Growth: 2.7Profit: 2.0Value: 5.0Quality: 3.0
Piotroski: 3/9Altman Z: -1.19

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 5.0
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for OPAD.

WELLSignificantly Overvalued (-87.0%)

Margin of Safety

-87.0%

Fair Value

$125.97

Current Price

$234.29

$108.32 premium

UndervaluedFair: $125.97Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

OPAD1 strengths · Avg: 10.0/10
Price/BookValuation
0.5x10/10

Reasonable price relative to book value

WELL3 strengths · Avg: 9.0/10
Revenue GrowthGrowth
39.1%10/10

Revenue surging 39.1% year-over-year

Market CapQuality
$169.78B9/10

Large-cap with strong market position

EPS GrowthGrowth
35.6%8/10

Earnings expanding 35.6% YoY

Areas to Watch

OPAD4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$21.29M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-90.4%2/10

ROE of -90.4% — below average capital efficiency

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
2.9%3/10

ROE of 2.9% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
105.2x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : OPAD

The strongest argument for OPAD centers on Price/Book.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, Market Cap, EPS Growth. Revenue growth of 39.1% demonstrates continued momentum.

Bear Case : OPAD

The primary concerns for OPAD are EPS Growth, Market Cap, Piotroski F-Score. Debt-to-equity of 3.04 is elevated, increasing financial risk.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 105.2x leaves little room for execution misses.

Key Dynamics to Monitor

OPAD profiles as a turnaround stock while WELL is a growth play — different risk/reward profiles.

OPAD carries more volatility with a beta of 2.50 — expect wider price swings.

WELL is growing revenue faster at 39.1% — sustainability is the question.

WELL generates stronger free cash flow (881M), providing more financial flexibility.

Bottom Line

WELL scores higher overall (57/100 vs 34/100) and 39.1% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Offerpad Solutions Inc. Class A Common Stock

REAL ESTATE · REAL ESTATE SERVICES · USA

Offerpad Solutions Inc (OPAD) is a forward-thinking, technology-driven real estate disruptor that revolutionizes the home buying and selling process through its sophisticated digital platform. Utilizing proprietary algorithms and data analytics, Offerpad enhances customer experience with instant cash offers, personalized move-out solutions, and a suite of ancillary services. As a prominent player in the expanding iBuyer sector, the company is well-equipped for ongoing growth, driven by its dedication to innovation, operational efficiency, and exceptional customer satisfaction. This strategic positioning within a dynamic market landscape makes Offerpad an attractive investment opportunity for institutional investors.

Visit Website →

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?